82
chapter 5 
Thermodynamics, Chemical Kinetics, and Energy Metabolism
from the third group; and from the fourth group by 
selection of whole-grain products (See also 
Chapter 9).
5.6 Obesity
The first law of thermodynamics states that the amount of 
stored energy equals the difference between energy intake 
and energy expenditure. The principal storage of energy 
is that of triglycerides in adipose tissue. Energy stores are 
essential for survival during times of energy deprivation 
(Chapters 18 and 22).
Energy stores in an adult are maintained at a relatively 
constant level throughout life. However, even a small im-
balance in energy intake over long periods of time will 
have a significant effect on energy storage. For example, 
suppose a non obese adult’s energy intake exceeds expen-
diture by about 1
% daily for one year. This amounts to 
an excess of 9,000 kcal and corresponds to a weight gain 
of about 2.5 lb (1.15 kg) per year. 3,500 kcal of chemi-
cal energy is equivalent to 1 lb (0.45 kg) of adipose tissue. 
Weight gain in most people is attributable to overconsump-
tion of palatable, energy-dense foods (e.g., lipids) and a 
sedentary lifestyle. Childhood obesity is a risk factor for 
obesity in adulthood.
Obesity is a consequence of a positive energy bal-
ance, i.e., input is greater than output. Body mass index 
(BMI) is the most useful parameter in assessing the mag-
nitude of obesity (Table 5-6). A BMI of 19-25 is consid-
ered healthy, 26-29.9 is moderately overweight, and 30 
or greater is obese. Obesity is the most common health 
problem in the developed world, and it is estimated that 
obesity affects about one third of the U.S. adult popula-
tion. In developed nations, the prevalence of obesity is 
higher among economically deprived people, whereas in 
developing nations, the relatively affluent have a higher 
risk.
A BMI greater than 28 is an independent risk factor 
(3^4 times higher than the general population) for cardio-
vascular diseases (Chapter 20), diabetes mellitus type 
2 (Chapter 22), and stroke. The prevalence of obesity- 
associated morbidity depends on the location of fat distri-
bution in the body. Intra-abdominal or visceral fat deposits 
are associated with higher health risks than gluteofemoral 
adipose tissue fat accumulation.
In experimental animals and possibly in humans, en-
ergy intake influences the aging process as well as the 
onset of aging-associated diseases. Energy restriction in 
animals, without altering their optimal nutritional status, 
increases the average life span but not the maximal life
span. This beneficial biological response to energy re-
striction has been attributed to the attenuation of oxida-
tive damage to proteins, lipids, and DNA (Chapter 14). 
During aging, despite increased body fat, there is a lin-
ear decrease in food intake and metabolism over the life 
span.
Biochemical M ediators of Obesity
The regulation of energy intake and expenditure is 
achieved by coordinating the effects of endocrine media-
tors and neural signals that arise from adipose tissue, en-
docrine glands, neurological and gastrointestinal systems. 
All of the information finally is integrated by the central 
nervous system (Figure 5-6).
One of the most significant mediators of the energy 
store in the adipose tissue is 
leptin
(from the Greek 
leptos,
meaning “thin”). Leptin is a protein of 167 amino acid 
residues that is synthesized in adipocytes. Its synthesis is 
increased by insulin, glucocorticoids, and estrogens and 
is decreased by ^-adrenergic agonists. The role of leptin 
in obesity comes from studies on rodents. In genetically 
obese mice (Ob/Ob), the observed gross obesity is due to 
absence of leptin production in the adipocytes. Leptin’s 
action on energy metabolism is mediated by receptors in 
many cells and it binds specifically to a receptor in the 
hypothalamus.
The action of leptin involves at least two pathways. Dur-
ing starvation and weight loss, adipose tissue is decreased 
with consequent low levels of leptin. The low level of lep-
tin leads to production of neuropeptide Y, which is syn-
thesized in the arcuate nucleus of the hypothalamus and is 
transported axonally to the paraventricular nucleus. Neu-
ropeptide Y binds to its receptor and functions as a potent 
appetite stimulant. The overall effect is increased appetite, 
decreased energy expenditure and temperature, decreased 
reproductive function (infertility), and increased parasym-
pathetic activity. An opposite set of events occurs when 
the leptin levels rise, except that the effects are mediated 
by melanocyte-stimulating hormone (MSH) that binds to 
the melanocortin 4 receptor (MC4-R). The MSH binding 
to MC4-R initiates several biological responses, includ-
ing decreased appetite, increased energy expenditure, and 
increased sympathetic activity (Figure 5-7).
In humans, obesity is a complex disease because of the 
redundancy of systems that regulate energy storage. There 
are inherited disorders of hyperphagia leading to obesity 
with associated clinical features such as hypogonadism 
and mental retardation. One hereditary disorder is 
Prader-
Willi syndrome
(Chapter 26), which is the most prevalent 
form of dysmorphic genetic obesity 
( 1
in 
1 0
,
0 0 0
-
2 0 , 0 0 0
 
    
